Clinical decision rules for acute bacterial meningitis: current insights

Area of Science:

• Neurology
• Infectious Diseases
• Medical Diagnostics

Background:

• Acute community-acquired bacterial meningitis (BM) necessitates prompt diagnosis and treatment within 60 minutes of patient admission.
• Lumbar puncture for cerebrospinal fluid (CSF) analysis is the primary diagnostic tool, but microbiological tests lack sensitivity.
• Standard CSF cytochemical markers (e.g., cell count, glucose, protein) often yield misleading results due to imprecise cutoff values.

Purpose of the Study:

• To review current diagnostic methods for acute community-acquired bacterial meningitis (BM).
• To evaluate the efficacy of various diagnostic markers, including standard CSF analysis, CSF lactate, and serum procalcitonin.
• To discuss the utility and limitations of predictive scores and models in BM diagnosis.

Main Methods:

• Review of current literature on bacterial meningitis diagnosis.
• Analysis of standard cerebrospinal fluid (CSF) cytochemical characteristics.
• Evaluation of novel biomarkers such as CSF lactate and serum procalcitonin.
• Assessment of diagnostic scores and predictive models.

Main Results:

• Standard CSF analysis for bacterial meningitis (BM) can be misleading.
• CSF lactate and serum procalcitonin levels demonstrate higher efficiency compared to standard markers.
• Predictive models offer clinical probability but require population-specific validation.

Conclusions:

• Accurate and timely diagnosis of bacterial meningitis (BM) is critical for effective treatment.
• CSF lactate and serum procalcitonin are more reliable indicators for BM diagnosis than traditional CSF markers.
• Further validation of predictive tools is necessary for widespread clinical application.